Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Country / region: Austria Clear all

161 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20043
20054
20066
20075
20083
20096
20106
20112
20122
20136
20144
20158
20169
20175
20189
20193
20208
202111
20228
20237
202415
202515
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Recruiting35
Active, not recruiting30
Terminated19
Withdrawn4
Not yet recruiting2
Unknown status2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
Hoffmann-La Roche12
Eli Lilly and Company11
Boehringer Ingelheim10
Bristol-Myers Squibb9
Merck Sharp & Dohme LLC7
Novartis Pharmaceuticals7
Amgen6
ETOP IBCSG Partners Foundation5
Pfizer5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung161
Lung Neoplasms33
Neoplasms13
Neoplasm Metastasis12
Carcinoma5
Colorectal Neoplasms5
Melanoma5
Small Cell Lung Carcinoma5
Adenocarcinoma4
Brain Neoplasms4

Trials

Showing 51 to 75 of 161. Each trial links to its page on Pharma Observatory.

61 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.